News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
PrEP
Pre-Exposure Prophylaxis: The Great Confusion

2011, the year of PrEP. In less than 18 months 6 clinical trials investigating the potential use of HIV antiretrovirals (ARV) for the prevention of HIV acquisition have rocked the HIV prevention world.

Published
25 November 2011
From
Incidence 0
HIV prevention policy
Key Issues Overlooked in Hillary Clinton's "AIDS Free Generation" Speech

There was no mention of pre-exposure prophylaxis (PrEP) or rectal microbicides -- two promising new areas of HIV prevention.

Published
17 November 2011
From
AIDS Foundation of Chicago
PrEP
How effective will biomedical approaches to HIV prevention be without behavioral programming?

Biomedical and behavioral scientists must come together to create effective and informed approaches to rolling out a bio-behavioral approach to HIV prevention. Biomedical strategies alone are not enough; behavioral approaches alone are simply not good enough.

Published
16 November 2011
From
Gay City News
Infectiousness and treatment as prevention
The goal of an AIDS-free generation: The time to invest in science is now

Now is the best possible moment to invest in research, when the possibilities for long-term success are greater than ever before.  This is when we should double down on some of the amazing successes we’ve seen in the past few years.

Published
15 November 2011
From
The Hill (blog)
Microbicides
First Combination ARV Vaginal Ring for HIV Prevention Being Tested in Phase I Safety Trial

In the first clinical trial of a vaginal ring combining two antiretroviral (ARV) drugs, researchers from the Microbicide Trials Network (MTN) are collaborating with the International Partnership for Microbicides (IPM) to evaluate whether the ring is safe for use in women. If the ring does prove to be safe, it could be considered for further testing, and eventually be evaluated for its effectiveness as a microbicide for protecting women against HIV infection through vaginal sex.

Published
15 November 2011
From
Microbicides Trials Network press release
Microbicides
HIV Vaginal Gel Nets Inaugural African Science Prize

The development of a vaginal gel that can cut a woman's risk of HIV infection by over 50% has been one of the few unqualified victories amid a decade of setbacks in HIV/AIDS research. Tomorrow, the husband-and-wife team of researchers who proved the gel's effectiveness will receive the inaugural Olusegun Obasanjo Prize from the African Academy of Sciences (AAS) at a ceremony in Nairobi, Kenya.

Published
09 November 2011
From
Science
Microbicides
Gel Cuts Women’s Risk of Herpes, Study Finds

A vaginal gel that sharply reduces a woman’s risk of infection with the AIDS virus is even more effective against genital herpes, a much more common risk for young American women, a new study has found.

Published
21 October 2011
From
New York Times
Advances in HIV biomedical prevention research: Why involving the Community is key

The first session of the European AIDS Conference in Belgrade next Wednesday will look at biomedical HIV prevention trials planned for Europe and how community involvement has been, and will be, essential in their planning and conduct. A joint presentation of EATG and the CHAARM microbicides research consortium. NAM's Gus Cairns is speaking on proposals for a PrEP trial in the UK.

Published
07 October 2011
From
EATG
PrEP
Tenofovir PrEP arm dropped in women's HIV prevention trial

A major HIV prevention trial comparing a tenofovir microbicide with two forms of oral pre-exposure prophylaxis as HIV prevention methods for women is to halt investigation of

Published
29 September 2011
By
Keith Alcorn
PrEP
MTN Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women

The decision to discontinue use of tenofovir tablets in VOICE comes after a routine review of study data concluded that the trial will not be able to demonstrate that tenofovir tablets are effective in preventing HIV in the women enrolled in the trial.

Published
29 September 2011
From
Microbicide Trials Network
← Prev1...34567...15Next →

Filter by country